C
cbdMD, Inc. (YCBD)
ASE – Real Time Price. Currency in USD
0.78
-0.02 (-2.97%)
At close: May 12, 2026, 3:59 PM EDT
0.80
+0.01 (1.62%)
After-hours: May 12, 2026, 7:39 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.78
-0.02 (-2.97%)
At close: May 12, 2026, 3:59 PM EDT
0.80
+0.01 (1.62%)
After-hours: May 12, 2026, 7:39 PM EDT
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
| Name | Position |
|---|---|
| Dr. Sibyl Swift Ph.D. | CSO, VP of Regulatory Affairs & Director |
| Mr. Bradley Whitford | Chief Accounting Officer, Treasurer & Secretary |
| Mr. David Johnson | Senior VP of Business Development |
| Mr. Francisco Mangual | Senior VP of Sales |
| Mr. Lance Blundell | General Counsel |
| Mr. T. Ronan Kennedy | CEO, CFO, Principal Executive Officer & Director |
| Mr. Zeb Booker | Chief Technology Officer |
| Ms. Shannon Charles | Chief Marketing Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-15 | 8-K | ycbd20260415_8k.htm |
| 2026-04-01 | 8-K | ycbd20260330_8k.htm |
| 2026-03-02 | CORRESP | filename1.htm |
| 2026-02-20 | S-1/A | ycbd20260218_s1a.htm |
| 2026-02-17 | 10-Q | ycbd20251231_10q.htm |
| 2026-02-12 | DEF 14A | ycbd20260209_def14a.htm |
| 2026-02-02 | PRE 14A | ycbd20260128_pre14a.htm |
| 2026-01-22 | S-1 | ycbd20260102c_s1.htm |
| 2026-01-20 | 10-K/A | ycbd20250930_10ka.htm |
| 2026-01-14 | 8-K | ycbd20260113_8k.htm |